查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1426980

流感診斷測試市場- 按測試類型（傳統診斷測試{RIDT、DFAT、病毒培養、血清學測定}、分子診斷測定{RT-PCR、LAMP、NASBAT、SAMBA}）、最終用途和預測，2023 年- 2032年

Influenza Diagnostic Tests Market - By Test Type (Traditional Diagnostic Test {RIDT, DFAT, Viral Culture, Serological Assay}, Molecular Diagnostic Assay {RT-PCR, LAMP, NASBAT, SAMBA}), End-use & Forecast, 2023 - 2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

由於全球流感反覆爆發，凸顯了對準確、快速診斷解決方案的迫切需求，預計 2023 年至 2032 年間，流感診斷測試市場的CAGR將達到 6.3%。根據世界衛生組織 2023 年 10 月的報告，每年約有 10 億例季節性流感病例，其中包括 300-500 萬例重症病例。當全世界都在努力應對流感的持續威脅時，診斷測試有助於早期發現、有效治療和遏制病毒。

診斷工具的不斷發展，包括分子檢測、快速抗原檢測和核酸擴增技術，提高了流感診斷的精確度和效率。對更靈敏、更特異和更快速的診斷方法的追求鼓勵了研發投資。

流感診斷測試產業根據測試類型、最終用途和地區進行細分。

分子診斷分析領域有望在預測期內大幅成長，因為聚合酶鏈反應（PCR）和核酸擴增測試在檢測流感病毒方面具有高靈敏度和特異性。這種精確度對於準確和及時的診斷非常重要，可以迅速啟動適當的治療和遏制措施。對快速、可靠的診斷解決方案的需求不斷成長，加上分子診斷技術的進步，促進了該領域的成長。

由於在推進診斷技術和方法方面發揮重要作用，研究實驗室部門將在 2023 年至 2032 年期間為市場帶來可觀的收入。研究實驗室幫助開發創新的診斷方法和不斷改進現有的測試平台。研究實驗室對卓越診斷準確性的追求直接轉化為更可靠、更有效率的測試的可用性，從而提高了診斷能力的整體標準。

由於快速的城市化、醫療保健意識的提高以及政府積極主動對抗傳染病，亞太地區流感診斷測試行業預計到 2032 年將顯著成長。流感發生率的增加，加上人們對傳染病的經濟影響的認知不斷提高，刺激了對精確診斷解決方案的需求。此外，醫療機構、政府和診斷公司之間的策略合作有助於更有效地應對流感疫情，有利於區域市場前景。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：流感診斷測試產業見解

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 流感流行率不斷上升
      • 快速診斷測試的需求增加
      • 技術進步
      • 研發活動增加
    • 產業陷阱與挑戰
      • 測試敏感性和特異性的差異
      • 嚴格的監管指引
  • 成長潛力分析
  • COVID-19 影響分析
  • 監管環境
  • 報銷場景
  • 技術景觀
  • 缺口分析
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 供應商矩陣分析
  • 戰略儀表板

第 5 章：流感診斷測試市場規模與預測：按測試類型

  • 主要測試類型趨勢
  • 傳統診斷測試
    • 流感快速診斷檢測 (RIDT)
    • 直接螢光抗體檢驗（DFAT）
    • 病毒培養
    • 血清學檢測
  • 分子診斷分析
    • 逆轉錄聚合酶連鎖反應
    • 基於環介導等溫擴增的測定 (LAMP)
    • 基於核酸序列的擴增檢驗 (NASBAT)
    • 基於簡單擴增的測定 (SAMBA)
    • 其他分子診斷測定

第 6 章：流感診斷測試市場規模與預測：依最終用途

  • 主要最終用途趨勢
  • 醫院
  • 診斷中心
  • 研究實驗室
  • 其他最終用戶

第 7 章：流感診斷測試市場規模與預測：按地區

  • 主要區域趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • MEA 的其餘部分

第 8 章：公司簡介

  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Becton, Dickinson and Company
  • Coris BioConcept
  • DiaSorin SpA
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Sekisui Diagnostics
  • Thermo Fischer Scientific Inc.
  • Hologic Inc.
Product Code: 4242

Influenza Diagnostic Tests Market is estimated to witness 6.3% CAGR between 2023 and 2032, owing to the recurrent global outbreaks of influenza that highlight the critical need for accurate and rapid diagnostic solutions. As per WHO October 2023 report, there were approximately a billion cases of seasonal influenza annually, which included 3-5 million cases of severe illness. As the world grapples with the ongoing threat of influenza, diagnostic tests help in early detection, effective treatment, and containment of the virus.

The continual evolution of diagnostic tools, including molecular assays, rapid antigen tests, and nucleic acid amplification techniques, enhances the precision and efficiency of influenza diagnosis. The quest for more sensitive, specific, and quicker diagnostic methods encourages R&D investments.

Influenza diagnostic tests industry is segmented on the basis of test type, end-use, and region.

Molecular diagnostic assays segment is poised for substantial growth over the forecast period, as polymerase chain reaction (PCR) and nucleic acid amplification tests, offer high sensitivity and specificity in detecting influenza viruses. This precision is important for accurate and timely diagnosis, allowing for prompt initiation of appropriate treatments and containment measures. The growing demand for rapid and reliable diagnostic solutions, coupled with advancements in molecular diagnostic technologies, contribute to the segment growth.

Research laboratories segment will generate notable revenues for the market during 2023-2032, owing to the instrumental role in advancing diagnostic technologies and methodologies. Research laboratories help in the development of innovative diagnostic assays and the continual improvement of existing testing platforms. The pursuit of excellence in diagnostic accuracy within research laboratories directly translates into the availability of more reliable and efficient tests, elevating the overall standard of diagnostic capabilities.

Asia Pacific influenza diagnostic tests industry is slated to witness a significant growth rate through 2032, attributed to rapid urbanization, increased healthcare awareness, and proactive government initiatives to combat infectious disease. The increasing incidence of influenza, coupled with a rising awareness of the economic impact of infectious diseases, fuels the demand for precise diagnostic solutions. Moreover, strategic collaborations between healthcare institutions, governments, and diagnostic companies contribute to a more efficient response to influenza outbreaks, favoring the regional market outlook.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & working
    • 1.2.1 Data collection
  • 1.3 Forecast parameters
  • 1.4 COVID-19 impact at global level
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Influenza diagnostic tests industry 360 degree synopsis, 2018 - 2032
  • 2.2 Business trends
  • 2.3 Regional trends
  • 2.4 Test type trend
  • 2.5 End-use trends

Chapter 3 Influenza Diagnostic Tests Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of influenza
      • 3.2.1.2 Rise in demand for rapid diagnostic tests
      • 3.2.1.3 Technological advancements
      • 3.2.1.4 Increase in R&D activities
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Variabilities in test sensitivity and specificity
      • 3.2.2.2 Stringent regulatory guidelines
  • 3.3 Growth potential analysis
    • 3.3.1 By test type
    • 3.3.2 By end-use
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Reimbursement scenario
  • 3.7 Technology landscape
  • 3.8 GAP analysis
  • 3.9 Porter's analysis
  • 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Company market share analysis, 2022
  • 4.4 Competitive positioning matrix
  • 4.5 Vendor matrix analysis
  • 4.6 Strategy dashboard, 2022

Chapter 5 Influenza Diagnostic Tests Market Size and Forecast, By Test Type (USD Million)

  • 5.1 Key test type trends
  • 5.2 Traditional diagnostic test
    • 5.2.1 Rapid influenza diagnostic test (RIDT)
    • 5.2.2 Direct fluorescent antibody test (DFAT)
    • 5.2.3 Viral culture
    • 5.2.4 Serological assay
  • 5.3 Molecular diagnostic assay
    • 5.3.1 RT-PCR
    • 5.3.2 Loop-mediated isothermal amplification-based Assay (LAMP)
    • 5.3.3 Nucleic acid sequence-based amplification test (NASBAT)
    • 5.3.4 Simple amplification-based assay (SAMBA)
    • 5.3.5 Other molecular diagnostic assays

Chapter 6 Influenza Diagnostic Tests Market Size and Forecast, By End-use (USD Million)

  • 6.1 Key end-use trends
  • 6.2 Hospitals
  • 6.3 Diagnostics centers
  • 6.4 Research laboratories
  • 6.5 Other end-users

Chapter 7 Influenza Diagnostic Tests Market Size and Forecast, By Region (USD Million)

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Spain
    • 7.3.5 Italy
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 South Korea
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 South Africa
    • 7.6.2 Saudi Arabia
    • 7.6.3 UAE
    • 7.6.4 Rest of MEA

Chapter 8 Company Profiles

  • 8.1 F. Hoffmann-La Roche Ltd
  • 8.2 Abbott
  • 8.3 Becton, Dickinson and Company
  • 8.4 Coris BioConcept
  • 8.5 DiaSorin SpA
  • 8.6 Meridian Bioscience Inc.
  • 8.7 Quidel Corporation
  • 8.8 Sekisui Diagnostics
  • 8.9 Thermo Fischer Scientific Inc.
  • 8.10 Hologic Inc.

Data Tables

  • TABLE 1. Product mapping
  • TABLE 2. Market revenue, by test type (2022)
  • TABLE 3. Market revenue, by end-use (2022)
  • TABLE 4. Market share, by region (2022)
  • TABLE 5. Competitive positioning matrix
  • TABLE 6. Vendor matrix analysis
  • TABLE 7. Traditional diagnostic test market size, 2018 - 2024 (USD Million)
  • TABLE 8. Traditional diagnostic test market size, 2025 - 2032 (USD Million)
  • TABLE 9. Rapid influenza diagnostic test (RIDT) market size, 2018 - 2024 (USD Million)
  • TABLE 10. Rapid influenza diagnostic test (RIDT) market size, 2025 - 2032 (USD Million)
  • TABLE 11. Direct fluorescent antibody test (DFAT) market size, 2018 - 2024 (USD Million)
  • TABLE 12. Direct fluorescent antibody test (DFAT) market size, 2025 - 2032 (USD Million)
  • TABLE 13. Viral culture market size, 2018 - 2024 (USD Million)
  • TABLE 14. Viral culture market size, 2025 - 2032 (USD Million)
  • TABLE 15. Hospital market size, 2018 - 2024 (USD Million)
  • TABLE 16. Hospital market size, 2025 - 2032 (USD Million)
  • TABLE 17. Assisted living market size, 2018 - 2024 (USD Million)
  • TABLE 18. Assisted living market size, 2025 - 2032 (USD Million)
  • TABLE 19. Serological assay market size, 2018 - 2024 (USD Million)
  • TABLE 20. Serological assay market size, 2025 - 2032 (USD Million)
  • TABLE 21. Molecular diagnostic assay market size, 2018 - 2024 (USD Million)
  • TABLE 22. Molecular diagnostic assay market size, 2025 - 2032 (USD Million)
  • TABLE 23. RT-PCR market size, 2018 - 2024 (USD Million)
  • TABLE 24. RT-PCR market size, 2025 - 2032 (USD Million)
  • TABLE 25. Loop-mediated isothermal amplification-based assay (LAMP) market size, 2018 - 2024 (USD Million)
  • TABLE 26. Loop-mediated isothermal amplification-based assay (LAMP) market size, 2025 - 2032 (USD Million)
  • TABLE 27. Nucleic acid sequence-based amplification test (NASBAT) market size, 2018 - 2024 (USD Million)
  • TABLE 28. Nucleic acid sequence-based amplification test (NASBAT) market size, 2025 - 2032 (USD Million)
  • TABLE 29. Simple amplification-based Assay (SAMBA) years market size, 2018 - 2024 (USD Million)
  • TABLE 30. Simple amplification-based Assay (SAMBA) years market size, 2025 - 2032 (USD Million)
  • TABLE 31. Other molecular diagnostic assays market size, 2018 - 2024 (USD Million)
  • TABLE 32. Other molecular diagnostic assays market size, 2025 - 2032 (USD Million)
  • TABLE 33. Hospitals years market size, 2018 - 2024 (USD Million)
  • TABLE 34. Hospitals years market size, 2025 - 2032 (USD Million)
  • TABLE 35. Diagnostics centers market size, 2018 - 2024 (USD Million)
  • TABLE 36. Diagnostics centers market size, 2025 - 2032 (USD Million)
  • TABLE 37. Research laboratories market size, 2018 - 2024 (USD Million)
  • TABLE 38. Research laboratories market size, 2025 - 2032 (USD Million)
  • TABLE 39. Other end-users market size, 2018 - 2024 (USD Million)
  • TABLE 40. Other end-users market size, 2025 - 2032 (USD Million)
  • TABLE 41. North America influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 42. North America influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 43. North America influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 44. North America influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 45. North America influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 46. North America influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 47. North America influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 48. North America influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 49. North America influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 50. North America influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 51. U.S. influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 52. U.S. influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 53. U.S. influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 54. U.S. influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 55. U.S. influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 56. U.S. influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 57. U.S. influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 58. U.S. influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 59. U.S. influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 60. U.S. influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 61. Canada influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 62. Canada influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 63. Canada influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 64. Canada influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 65. Canada influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 66. Canada influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 67. Canada influenza diagnostic tests market size, by payment source, 2018 - 2024, (USD Million)
  • TABLE 68. Canada influenza diagnostic tests market size, by payment source, 2025 - 2032, (USD Million)
  • TABLE 69. Canada influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 70. Canada influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 71. Europe influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 72. Europe influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 73. Europe influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 74. Europe influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 75. Europe influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 76. Europe influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 77. Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 78. Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 79. Europe influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 80. Europe influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 81. Germany influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 82. Germany influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 83. Germany influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 84. Germany influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 85. Germany influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 86. Germany influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 87. Germany influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 88. Germany influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 89. UK influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 90. UK influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 91. UK influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 92. UK influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 93. UK influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 94. UK influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 95. UK influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 96. UK influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 97. France influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 98. France influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 99. France influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 100. France influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 101. France influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 102. France influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 103. France influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 104. France influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 105. Spain influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 106. Spain influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 107. Spain influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 108. Spain influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 109. Spain influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 110. Spain influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 111. Spain influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 112. Spain influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 113. Italy influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 114. Italy influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 115. Italy influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 116. Italy influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 117. Italy influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 118. Italy influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 119. Italy influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 120. Italy influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 121. Rest of Europe influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 122. Rest of Europe influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 123. Rest of Europe influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 124. Rest of Europe influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 125. Rest of Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 126. Rest of Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 127. Rest of Europe influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 128. Rest of Europe influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 129. Asia Pacific influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 130. Asia Pacific influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 131. Asia Pacific influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 132. Asia Pacific influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 133. Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 134. Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 135. Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 136. Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 137. Asia Pacific influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 138. Asia Pacific influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 139. China influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 140. China influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 141. China influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 142. China influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 143. China influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 144. China influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 145. China influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 146. China influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 147. Japan influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 148. Japan influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 149. Japan influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 150. Japan influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 151. Japan influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 152. Japan influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 153. Japan influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 154. Japan influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 155. India influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 156. India influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 157. India influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 158. India influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 159. India influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 160. India influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 161. India influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 162. India influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 163. Australia influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 164. Australia influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 165. Australia influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 166. Australia influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 167. Australia influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 168. Australia influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 169. Australia influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 170. Australia influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 171. South Korea influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 172. South Korea influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 173. South Korea influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 174. South Korea influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 175. South Korea influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 176. South Korea influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 177. South Korea influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 178. South Korea influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 179. Rest of Asia Pacific influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 180. Rest of Asia Pacific influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 181. Rest of Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 182. Rest of Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 183. Rest of Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 184. Rest of Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 185. Rest of Asia Pacific influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 186. Rest of Asia Pacific influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 187. Latin America influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 188. Latin America influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 189. Latin America influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 190. Latin America influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 191. Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 192. Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 193. Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 194. Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 195. Latin America influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 196. Latin America influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 197. Brazil influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 198. Brazil influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 199. Brazil influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 200. Brazil influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 201. Brazil influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 202. Brazil influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 203. Brazil influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 204. Brazil influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 205. Mexico influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 206. Mexico influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 207. Mexico influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 208. Mexico influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 209. Mexico influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 210. Mexico influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 211. Mexico influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 212. Mexico influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 213. Argentina influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 214. Argentina influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 215. Argentina influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 216. Argentina influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 217. Argentina influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 218. Argentina influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 219. Argentina influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 220. Argentina influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 221. Rest of Latin America influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 222. Rest of Latin America influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 223. Rest of Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 224. Rest of Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 225. Rest of Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 226. Rest of Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 227. Rest of Latin America influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 228. Rest of Latin America influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 229. MEA influenza diagnostic tests market size, by country, 2018 - 2024, (USD Million)
  • TABLE 230. MEA influenza diagnostic tests market size, by country, 2025 - 2032, (USD Million)
  • TABLE 231. MEA influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 232. MEA influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 233. MEA influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 234. MEA influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 235. MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 236. MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 237. MEA influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 238. MEA influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 239. South Africa influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 240. South Africa influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 241. South Africa influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 242. South Africa influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 243. South Africa influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 244. South Africa influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 245. South Africa influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 246. South Africa influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 247. Saudi Arabia influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 248. Saudi Arabia influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 249. Saudi Arabia influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 250. Saudi Arabia influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 251. Saudi Arabia influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 252. Saudi Arabia influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 253. Saudi Arabia influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 254. Saudi Arabia influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 255. Saudi Arabia influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 256. Saudi Arabia influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 257. UAE influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 258. UAE influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 259. UAE influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 260. UAE influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 261. UAE influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 262. UAE influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 263. UAE influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 264. UAE influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)
  • TABLE 265. Rest of MEA influenza diagnostic tests market size, by test type, 2018 - 2024, (USD Million)
  • TABLE 266. Rest of MEA influenza diagnostic tests market size, by test type, 2025 - 2032, (USD Million)
  • TABLE 267. Rest of MEA influenza diagnostic tests market size, by traditional diagnostic test, 2018 - 2024, (USD Million)
  • TABLE 268. Rest of MEA influenza diagnostic tests market size, by traditional diagnostic test, 2025 - 2032, (USD Million)
  • TABLE 269. Rest of MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2018 - 2024, (USD Million)
  • TABLE 270. Rest of MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2025 - 2032, (USD Million)
  • TABLE 271. Rest of MEA influenza diagnostic tests market size, by end-use, 2018 - 2024, (USD Million)
  • TABLE 272. Rest of MEA influenza diagnostic tests market size, by end-use, 2025 - 2032, (USD Million)

Charts & Figures

  • FIG. 1 GMI report coverage: Critical research elements
  • FIG. 2 Industry segmentation
  • FIG. 3 Top-down approach
  • FIG. 4 Market estimation and forecast methodology
  • FIG. 5 Market forecasting methodology
  • FIG. 6 Breakdown of primary participants
  • FIG. 7 Influenza diagnostic tests industry 360 degree synopsis, 2018 - 2032
  • FIG. 8 Industry ecosystem analysis
  • FIG. 9 Industry impact forces
  • FIG. 10 Growth potential analysis, by test type
  • FIG. 11 Growth potential analysis, by end-use
  • FIG. 12 GAP analysis
  • FIG. 13 Porter's analysis
  • FIG. 14 PESTEL analysis
  • FIG. 15 Company matrix analysis, 2022
  • FIG. 16 Global company market share analysis, 2022
  • FIG. 17 Competitive positioning matrix
  • FIG. 18 Strategy dashboard, 2022